Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Melbana Energy Limited (MAY)
  6. Company Announcements

Melbana Energy Limited (ASX: MAY) - Announcements

Current share price for MAY : $0.053 0.002 (3.64%)

ASX company news and announcements for Melbana Energy Limited (MAY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Melbana Energy Limited (MAY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Melbana Energy Limited (MAY), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Melbana Energy Limited (MAY)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$179 MELBANA ENERGY - WA-488-P Work Program Variation 28 Nov 2016 10:05AM $0.026 $0.053 $0.053 risen by 103.85%
$179 Cuba Block 9 Update 23 Nov 2016 9:14AM $0.027 $0.053 $0.053 risen by 96.30%
$179 Appendix 3B - New issue announcement 14 Nov 2016 11:53AM $0.027 $0.053 $0.053 risen by 96.30%
$179 Appendix 3Y - Michael Sandy - 14 Nov 2016 14 Nov 2016 9:45AM $0.028 $0.053 $0.053 risen by 89.29%
$179 Melbana Energy commences trading under new ASX ticker MAY 8 Nov 2016 9:39AM n/a $0.053 $0.053 n/a
$179 Open Briefing. Mayne. CEO Elect on Mayne Pharma 10 Nov 2005 9:37AM $5.640 $0.053 $0.053 fallen by 99.06%
$179 Receives US Court Judgement For Propofol 3 Nov 2005 3:55PM $5.330 $0.053 $0.053 fallen by 99.01%
$179 Preliminary Final Report 24 Aug 2005 8:36AM $4.950 $0.053 $0.053 fallen by 98.93%
$179 Mayne Receives Australian Court Decision for Epirubicin 5 Aug 2005 2:03PM $4.790 $0.053 $0.053 fallen by 98.89%
$179 Mayne Pharma Provides Strategic Update 1 Jul 2005 9:38AM $4.740 $0.053 $0.053 fallen by 98.88%
$179 Update Regarding Proposed Demerger 17 Jun 2005 10:00AM $4.630 $0.053 $0.053 fallen by 98.86%
$179 Share Buy-Back 12 May 2005 4:39PM $4.200 $0.053 $0.053 fallen by 98.74%
$179 Final Share Buy-Back Notice 23 Mar 2005 9:15AM $3.850 $0.053 $0.053 fallen by 98.62%
$179 Mayne expands UK Aseptic Manufacturing Services 25 Feb 2005 10:13AM $4.040 $0.053 $0.053 fallen by 98.69%
$179 Media release re half yearly results 23 Feb 2005 8:30AM $4.120 $0.053 $0.053 fallen by 98.71%
$179 Mayne & Strides broaden supply & distribution partnership 2 Feb 2005 6:00PM $4.770 $0.053 $0.053 fallen by 98.89%
$179 Sells Port Macquarie Base Hospital to NSW Government 23 Dec 2004 11:58AM $4.250 $0.053 $0.053 fallen by 98.75%
$179 Mayne Pharma & Strides Sign Development & Supply Agreement 22 Dec 2004 9:14AM $4.230 $0.053 $0.053 fallen by 98.75%
$179 Prices US$200M 144A/Reg S Issue 17 Nov 2004 9:54AM $4.300 $0.053 $0.053 fallen by 98.77%
$179 Receives final approval & launches Carboplatin in the US 15 Oct 2004 10:04AM $4.130 $0.053 $0.053 fallen by 98.72%
$179 Mayne signs agreement with Intas 20 Sep 2004 9:09AM $3.880 $0.053 $0.053 fallen by 98.63%
$179 Obtains European Paclitaxel Patent 25 Aug 2004 2:47PM $3.960 $0.053 $0.053 fallen by 98.66%
$179 AFY: T'fer of Noosa/Caboolture Private & Logon Private Hosps 2 Jul 2004 4:19PM $3.390 $0.053 $0.053 fallen by 98.44%
$179 AFY ann:Transfer of Frances Perry House to Affinity Health 17 Jun 2004 4:14PM $3.260 $0.053 $0.053 fallen by 98.37%
$179 Launches paclitaxel in Europe 4 May 2004 10:02AM $3.180 $0.053 $0.053 fallen by 98.33%

526 - 550 of 576 results

Page 22 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.